Those aspiring to outpace the market meticulously engage in the process of selecting individual stocks. Strategic choices can be instrumental in accelerating your wealth.
After finishing at $3.62 in the prior trading day, LifeMD Inc (NASDAQ: LFMD) closed at $3.58, down -1.10%. In other words, the price has decreased by -$1.10 from its previous closing price. On the day, 0.8 million shares were traded. LFMD stock price reached its highest trading level at $3.76 during the session, while it also had its lowest trading level at $3.5399.
Ratios:
Our goal is to gain a better understanding of LFMD by taking a closer look at its different ratios. It provided that stocks Price–to–Cash (P/C) ratio for the trailing twelve months (TTM) is standing at 7.24 whereas its Price-to-Free Cash Flow (P/FCF) for the term is 15.40. For the most recent quarter (mrq), Quick Ratio is recorded 0.66 and its Current Ratio is at 0.73. In the meantime, Its Debt-to-Equity ratio is 4.98 whereas as Long-Term Debt/Eq ratio is at 4.47.
Upgrades & Downgrades
In the most recent recommendation for this company, BTIG Research on June 18, 2025, Reiterated its Buy rating but revised its target price to $18 from $15 previously.
On December 10, 2024, Lake Street started tracking the stock assigning a Buy rating and target price of $12.
On December 04, 2024, Mizuho started tracking the stock assigning a Neutral rating and target price of $7.Mizuho initiated its Neutral rating on December 04, 2024, with a $7 target price.
Insider Transactions:
The insider trade also gives investors a glimpse into the future direction of stock prices, which can be beneficial to investors. A recent insider transaction in this stock occurred on Dec 09 ’25 when FRIEDEMAN JESSICA sold 15,000 shares for $3.61 per share. The transaction valued at 54,158 led to the insider holds 205,000 shares of the business.
FRIEDEMAN JESSICA bought 20,000 shares of LFMD for $80,800 on Nov 24 ’25. On Sep 10 ’25, another insider, Alvarez Nicholas P, who serves as the Chief Acquisition Officer of the company, sold 75,000 shares for $5.92 each. As a result, the insider received 443,760 and left with 605,000 shares of the company.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, LFMD now has a Market Capitalization of 172326464 and an Enterprise Value of 157119808. For the stock, the TTM Price-to-Sale (P/S) ratio is 0.68 while its Price-to-Book (P/B) ratio in mrq is 126.91. Its current Enterprise Value per Revenue stands at 0.628 whereas that against EBITDA is -115.333.
Stock Price History:
The Beta on a monthly basis for LFMD is 1.89, which has changed by -0.3048544 over the last 52 weeks, in comparison to a change of 0.15024745 over the same period for the S&P500. Over the past 52 weeks, LFMD has reached a high of $15.84, while it has fallen to a 52-week low of $3.18. The 50-Day Moving Average of the stock is -5.45%, while the 200-Day Moving Average is calculated to be -50.81%.
Shares Statistics:
The stock has traded on average 1.31M shares per day over the past 3-months and 980330 shares per day over the last 10 days, according to various share statistics. A total of 46.58M shares are outstanding, with a floating share count of 39.43M. Insiders hold about 18.09% of the company’s shares, while institutions hold 42.32% stake in the company. Shares short for LFMD as of 1767139200 were 5101766 with a Short Ratio of 3.91, compared to 1764288000 on 4863721. Therefore, it implies a Short% of Shares Outstanding of 5101766 and a Short% of Float of 12.690000000000001.
Earnings Estimates
A detailed examination of LifeMD Inc (LFMD) is currently in progress, with 2.0 analysts providing valuable insights into its market dynamics.The consensus estimate for the next quarter is $0.03, with high estimates of $0.12 and low estimates of -$0.07.
Analysts are recommending an EPS of between $0.42 and -$0.23 for the fiscal current year, implying an average EPS of $0.09. EPS for the following year is $0.14, with 2.0 analysts recommending between $0.55 and -$0.26.
Revenue Estimates
8 analysts predict $48.57M in revenue. The current quarter. It ranges from a high estimate of $58M to a low estimate of $45M. The current estimate, LifeMD Inc’s year-ago sales were $64.25MFor the next quarter, 8 analysts are estimating revenue of $50.07M. There is a high estimate of $58.75M for the next quarter, whereas the lowest estimate is $47.1M.
A total of 8 analysts have provided revenue estimates for LFMD’s current fiscal year. The highest revenue estimate was $246.1M, while the lowest revenue estimate was $233.09M, resulting in an average revenue estimate of $236.72M. In the same quarter a year ago, actual revenue was $212.45MBased on 8 analysts’ estimates, the company’s revenue will be $224.04M in the next fiscal year. The high estimate is $249.2M and the low estimate is $197M.
